Cart summary

You have no items in your shopping cart.

GSK343

SKU: orb1301110

Description

GSK343

Research Area

Cell Biology, Epigenetics & Chromatin

Images & Validation

Key Properties

CAS Number1346704-33-3
MW541.69
Purity99.90%
FormulaC31H39N7O2
SMILESCCCc1cc(C)[nH]c(=O)c1CNC(=O)c1cc(cc2n(ncc12)C(C)C)-c1ccnc(c1)N1CCN(C)CC1
TargetAutophagy,Histone Methyltransferase
SolubilityDMSO:22.27 mg/mL (41.11 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (1.85 mM)

Bioactivity

Target IC50
EZH2:4 nM
In Vivo
Mice treated with GSK343 (5 mg/kg) displayed significantly inhibited tumor growth compared to the control group. The average volume and weight of tumors in the GSK343-treated group were notably decreased. This reduction in tumor growth was evident as early as 20 days post-implantation and continued throughout the study. Furthermore, in the GSK343-treated animals within the xenograft model, there was a substantial increase in the levels of E-cadherin mRNA, alongside a significant decrease in vimentin mRNA levels, compared to the control group.
Cell Research
To account for varying doubling rates among cancer cell lines, the optimal cell seeding is determined empirically for all cell lines by examining their growth in a 384-well plate over 6 days with a wide range of seeding densities. Cells are then plated at the optimal seeding density and allowed to adhere overnight. Cells are treated in duplicate with a 20-point 2-fold dilution series of compound or 0.147% DMSO (vehicle control) and incubated for 6 days at 37C in 5% CO2. Cells are then lysed with 25 μl CellTiter-Glo per well and chemiluminescence is quantified with a TECAN Safire2 microplate reader. In addition, an untreated plate of cells is harvested at the time of compound addition (T0) to quantify the starting number of cells. CTG values after 6 days of treatment were expressed as a percent of the T0 value and plotted against compound concentration. Data are fit with a 4-parameter equation to generate a concentration response curve and the concentration of compound required to inhibit 50% of growth (gIC50) is determined(Only for Reference)

Storage & Handling

Storagekeep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

Autophagy, EZH2, EZH1, GSK 343, GSK343, GSK-343, Inhibitor, Histone Methyltransferase, HistoneMethyltransferase, inhibit

Similar Products

  • GSK343 [orb1226482]

    >98% (HPLC)

    1346704-33-3

    541.69

    C31H39N7O2

    100 mg, 5 mg, 10 mg, 25 mg, 1 g, 500 mg, 200 mg, 50 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

GSK343 (orb1301110)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

5 mg
$ 100.00
1 ml x 10 mM (in DMSO)
$ 110.00
10 mg
$ 130.00
25 mg
$ 230.00
50 mg
$ 340.00
100 mg
$ 580.00
DispatchUsually dispatched within 3-5 working days
Bulk Enquiry